학술논문

A0596 - First safety and efficacy results of the TAR-210 erdafitinib intravesical delivery system in patients with non–muscle-invasive bladder cancer with select FGFR alterations.
Document Type
Article
Source
European Urology. 2024 Supplement 1, Vol. 85, pS1506-S1507. 2p.
Subject
*NON-muscle invasive bladder cancer
Language
ISSN
0302-2838